In-vitro Diagnostics (IVD) Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
Description
Persistence Market Research has recently released a comprehensive report on the global In-vitro Diagnostics (IVD) Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.
Key Insights:
The in-vitro diagnostics (IVD) market encompasses a broad range of diagnostic tests and systems that analyze biological samples such as blood, urine, and tissues outside the human body to detect diseases, conditions, and infections. IVD is undergoing a significant transformation driven by precision medicine, decentralized care models, and a surging focus on early disease detection. As a core pillar of modern healthcare systems, IVD enables real-time clinical decision-making and supports both routine screening and complex genomic profiling. The market is witnessing rapid innovations in molecular platforms, digital integration, automation, and data analytics, enhancing diagnostic accuracy and operational efficiency across healthcare settings.
Market Growth Drivers:
The growth of the global in-vitro diagnostics market is primarily driven by the rising prevalence of chronic and infectious diseases, including diabetes, cancer, cardiovascular disorders, and emerging viral infections. The increasing adoption of precision medicine and personalized treatment approaches has significantly boosted demand for advanced molecular diagnostics and genomic testing. Additionally, the shift toward decentralized healthcare and point-of-care testing solutions is enabling faster diagnosis and improved patient outcomes, especially in remote and underserved regions. Growing healthcare expenditure, expanding laboratory infrastructure, and technological advancements in automation and digital integration are further accelerating market expansion.
Market Restraints:
Despite strong growth prospects, the IVD market faces certain restraints. High costs associated with advanced diagnostic instruments and molecular testing platforms can limit adoption, particularly in low- and middle-income countries. Stringent regulatory requirements and lengthy approval processes for new diagnostic products may delay market entry and innovation. Moreover, reimbursement challenges and pricing pressures in developed markets can impact profitability for manufacturers. Limited access to skilled laboratory professionals in some regions also poses operational challenges for effective deployment of sophisticated diagnostic systems.
Market Opportunities:
The IVD market presents substantial opportunities driven by advancements in molecular diagnostics, artificial intelligence integration, and automation technologies. The increasing demand for home-based and point-of-care testing solutions opens new avenues for decentralized diagnostics and remote patient monitoring. Expansion in emerging markets across Asia-Pacific, Latin America, and the Middle East & Africa offers untapped growth potential due to improving healthcare infrastructure and rising awareness of early disease detection. Strategic collaborations between diagnostic companies, research institutions, and healthcare providers, along with investments in next-generation sequencing and companion diagnostics, are expected to create significant competitive advantages and long-term growth prospects.
Key Questions Answered in the Report:
Leading companies in the global IVD market are focusing on expanding their product portfolios through continuous innovation in molecular diagnostics, immunoassays, and automation platforms. Strategic mergers and acquisitions, partnerships with healthcare institutions, and investments in research and development are key approaches adopted to enhance technological capabilities and global footprint. Companies are also emphasizing digital integration, AI-driven analytics, and decentralized testing solutions to meet evolving clinical needs. Strengthening distribution networks and expanding presence in emerging markets remain central to sustaining competitive advantage.
Companies Covered in This Report:
By Product Type
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- In-vitro Diagnostics (IVD) Market Size (2025E): US$ 77.4 Bn
- Projected Market Value (2032F): US$ 117.9 Bn
- Global Market Growth Rate (CAGR 2025 to 2032): 6.2%
The in-vitro diagnostics (IVD) market encompasses a broad range of diagnostic tests and systems that analyze biological samples such as blood, urine, and tissues outside the human body to detect diseases, conditions, and infections. IVD is undergoing a significant transformation driven by precision medicine, decentralized care models, and a surging focus on early disease detection. As a core pillar of modern healthcare systems, IVD enables real-time clinical decision-making and supports both routine screening and complex genomic profiling. The market is witnessing rapid innovations in molecular platforms, digital integration, automation, and data analytics, enhancing diagnostic accuracy and operational efficiency across healthcare settings.
Market Growth Drivers:
The growth of the global in-vitro diagnostics market is primarily driven by the rising prevalence of chronic and infectious diseases, including diabetes, cancer, cardiovascular disorders, and emerging viral infections. The increasing adoption of precision medicine and personalized treatment approaches has significantly boosted demand for advanced molecular diagnostics and genomic testing. Additionally, the shift toward decentralized healthcare and point-of-care testing solutions is enabling faster diagnosis and improved patient outcomes, especially in remote and underserved regions. Growing healthcare expenditure, expanding laboratory infrastructure, and technological advancements in automation and digital integration are further accelerating market expansion.
Market Restraints:
Despite strong growth prospects, the IVD market faces certain restraints. High costs associated with advanced diagnostic instruments and molecular testing platforms can limit adoption, particularly in low- and middle-income countries. Stringent regulatory requirements and lengthy approval processes for new diagnostic products may delay market entry and innovation. Moreover, reimbursement challenges and pricing pressures in developed markets can impact profitability for manufacturers. Limited access to skilled laboratory professionals in some regions also poses operational challenges for effective deployment of sophisticated diagnostic systems.
Market Opportunities:
The IVD market presents substantial opportunities driven by advancements in molecular diagnostics, artificial intelligence integration, and automation technologies. The increasing demand for home-based and point-of-care testing solutions opens new avenues for decentralized diagnostics and remote patient monitoring. Expansion in emerging markets across Asia-Pacific, Latin America, and the Middle East & Africa offers untapped growth potential due to improving healthcare infrastructure and rising awareness of early disease detection. Strategic collaborations between diagnostic companies, research institutions, and healthcare providers, along with investments in next-generation sequencing and companion diagnostics, are expected to create significant competitive advantages and long-term growth prospects.
Key Questions Answered in the Report:
- What are the primary factors driving the global in-vitro diagnostics (IVD) market's growth?
- Which regions and segments are experiencing the highest demand for IVD products and services?
- How are innovations in molecular diagnostics and digital health technologies shaping market trends?
- Who are the leading players in the IVD market, and what strategies are they adopting to strengthen their market position?
- What are the future growth prospects and emerging opportunities in the global IVD market?
Leading companies in the global IVD market are focusing on expanding their product portfolios through continuous innovation in molecular diagnostics, immunoassays, and automation platforms. Strategic mergers and acquisitions, partnerships with healthcare institutions, and investments in research and development are key approaches adopted to enhance technological capabilities and global footprint. Companies are also emphasizing digital integration, AI-driven analytics, and decentralized testing solutions to meet evolving clinical needs. Strengthening distribution networks and expanding presence in emerging markets remain central to sustaining competitive advantage.
Companies Covered in This Report:
- Abbott Laboratories
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- QIAGEN
- Becton, Dickinson and Company
- Danaher
- BIOMÉRIEUX
- Agilent Technologies, Inc.
- Quest Diagnostics Incorporated
By Product Type
- Instruments
- Reagents
- Others
- Immunoassay
- Hematology
- Clinical Chemistry
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
- Point-of-care
- Home Care
- Others
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Diseases
- Drug Testing
- Others
- Hospitals
- Laboratories
- Home Care
- Others
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
192 Pages
- 1. Executive Summary
- 1.1. Global In-vitro Diagnostics (IVD) Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Regulatory Landscape
- 3.2. Product Type Adoption Analysis
- 3.3. Value Chain Analysis
- 3.4. Key Deals and Mergers
- 3.5. PESTLE Analysis
- 3.6. Porter’s Five Force Analysis
- 4. Global In-vitro Diagnostics (IVD) Market Outlook
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 4.3. Global In-vitro Diagnostics (IVD) Market Outlook: Product Type
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 4.3.3.1. Instruments
- 4.3.3.2. Reagents
- 4.3.3.3. Others
- 4.3.4. Market Attractiveness Analysis: Product Type
- 4.4. Global In-vitro Diagnostics (IVD) Market Outlook: Technology
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 4.4.3.1. Immunoassay
- 4.4.3.2. Hematology
- 4.4.3.3. Clinical Chemistry
- 4.4.3.4. Molecular Diagnostics
- 4.4.3.5. Coagulation
- 4.4.3.6. Microbiology
- 4.4.3.7. Others
- 4.4.4. Market Attractiveness Analysis: Technology
- 4.5. Global In-vitro Diagnostics (IVD) Market Outlook: Test
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Test, 2019-2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
- 4.5.3.1. Point-of-care
- 4.5.3.2. Home Care
- 4.5.3.3. Others
- 4.5.4. Market Attractiveness Analysis: Test
- 4.6. Global In-vitro Diagnostics (IVD) Market Outlook: Application
- 4.6.1. Introduction / Key Findings
- 4.6.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 4.6.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 4.6.3.1. Infectious Diseases
- 4.6.3.2. Diabetes
- 4.6.3.3. Oncology
- 4.6.3.4. Cardiology
- 4.6.3.5. Nephrology
- 4.6.3.6. Autoimmune Diseases
- 4.6.3.7. Drug Testing
- 4.6.3.8. Others
- 4.6.4. Market Attractiveness Analysis: Application
- 4.7. Global In-vitro Diagnostics (IVD) Market Outlook: End-use
- 4.7.1. Introduction / Key Findings
- 4.7.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019-2024
- 4.7.3. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
- 4.7.3.1. Hospitals
- 4.7.3.2. Laboratories
- 4.7.3.3. Home Care
- 4.7.3.4. Others
- 4.7.4. Market Attractiveness Analysis: End-use
- 5. Global In-vitro Diagnostics (IVD) Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
- 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
- 6. North America In-vitro Diagnostics (IVD) Market Outlook
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Product Type
- 6.2.3. By Technology
- 6.2.4. By Test
- 6.2.5. By Application
- 6.2.6. By End-use
- 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 6.4.1. Instruments
- 6.4.2. Reagents
- 6.4.3. Others
- 6.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 6.5.1. Immunoassay
- 6.5.2. Hematology
- 6.5.3. Clinical Chemistry
- 6.5.4. Molecular Diagnostics
- 6.5.5. Coagulation
- 6.5.6. Microbiology
- 6.5.7. Others
- 6.6. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
- 6.6.1. Point-of-care
- 6.6.2. Home Care
- 6.6.3. Others
- 6.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 6.7.1. Infectious Diseases
- 6.7.2. Diabetes
- 6.7.3. Oncology
- 6.7.4. Cardiology
- 6.7.5. Nephrology
- 6.7.6. Autoimmune Diseases
- 6.7.7. Drug Testing
- 6.7.8. Others
- 6.8. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
- 6.8.1. Hospitals
- 6.8.2. Laboratories
- 6.8.3. Home Care
- 6.8.4. Others
- 6.9. Market Attractiveness Analysis
- 7. Europe In-vitro Diagnostics (IVD) Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product Type
- 7.2.3. By Technology
- 7.2.4. By Test
- 7.2.5. By Application
- 7.2.6. By End-use
- 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
- 7.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 7.4.1. Instruments
- 7.4.2. Reagents
- 7.4.3. Others
- 7.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 7.5.1. Immunoassay
- 7.5.2. Hematology
- 7.5.3. Clinical Chemistry
- 7.5.4. Molecular Diagnostics
- 7.5.5. Coagulation
- 7.5.6. Microbiology
- 7.5.7. Others
- 7.6. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
- 7.6.1. Point-of-care
- 7.6.2. Home Care
- 7.6.3. Others
- 7.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.7.1. Infectious Diseases
- 7.7.2. Diabetes
- 7.7.3. Oncology
- 7.7.4. Cardiology
- 7.7.5. Nephrology
- 7.7.6. Autoimmune Diseases
- 7.7.7. Drug Testing
- 7.7.8. Others
- 7.8. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
- 7.8.1. Hospitals
- 7.8.2. Laboratories
- 7.8.3. Home Care
- 7.8.4. Others
- 7.9. Market Attractiveness Analysis
- 8. East Asia In-vitro Diagnostics (IVD) Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product Type
- 8.2.3. By Technology
- 8.2.4. By Test
- 8.2.5. By Application
- 8.2.6. By End-use
- 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 8.4.1. Instruments
- 8.4.2. Reagents
- 8.4.3. Others
- 8.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 8.5.1. Immunoassay
- 8.5.2. Hematology
- 8.5.3. Clinical Chemistry
- 8.5.4. Molecular Diagnostics
- 8.5.5. Coagulation
- 8.5.6. Microbiology
- 8.5.7. Others
- 8.6. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
- 8.6.1. Point-of-care
- 8.6.2. Home Care
- 8.6.3. Others
- 8.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.7.1. Infectious Diseases
- 8.7.2. Diabetes
- 8.7.3. Oncology
- 8.7.4. Cardiology
- 8.7.5. Nephrology
- 8.7.6. Autoimmune Diseases
- 8.7.7. Drug Testing
- 8.7.8. Others
- 8.8. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
- 8.8.1. Hospitals
- 8.8.2. Laboratories
- 8.8.3. Home Care
- 8.8.4. Others
- 8.9. Market Attractiveness Analysis
- 9. South Asia & Oceania In-vitro Diagnostics (IVD) Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product Type
- 9.2.3. By Technology
- 9.2.4. By Test
- 9.2.5. By Application
- 9.2.6. By End-use
- 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 9.4.1. Instruments
- 9.4.2. Reagents
- 9.4.3. Others
- 9.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 9.5.1. Immunoassay
- 9.5.2. Hematology
- 9.5.3. Clinical Chemistry
- 9.5.4. Molecular Diagnostics
- 9.5.5. Coagulation
- 9.5.6. Microbiology
- 9.5.7. Others
- 9.6. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
- 9.6.1. Point-of-care
- 9.6.2. Home Care
- 9.6.3. Others
- 9.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.7.1. Infectious Diseases
- 9.7.2. Diabetes
- 9.7.3. Oncology
- 9.7.4. Cardiology
- 9.7.5. Nephrology
- 9.7.6. Autoimmune Diseases
- 9.7.7. Drug Testing
- 9.7.8. Others
- 9.8. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
- 9.8.1. Hospitals
- 9.8.2. Laboratories
- 9.8.3. Home Care
- 9.8.4. Others
- 9.9. Market Attractiveness Analysis
- 10. Latin America In-vitro Diagnostics (IVD) Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product Type
- 10.2.3. By Technology
- 10.2.4. By Test
- 10.2.5. By Application
- 10.2.6. By End-use
- 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 10.4.1. Instruments
- 10.4.2. Reagents
- 10.4.3. Others
- 10.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 10.5.1. Immunoassay
- 10.5.2. Hematology
- 10.5.3. Clinical Chemistry
- 10.5.4. Molecular Diagnostics
- 10.5.5. Coagulation
- 10.5.6. Microbiology
- 10.5.7. Others
- 10.6. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
- 10.6.1. Point-of-care
- 10.6.2. Home Care
- 10.6.3. Others
- 10.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.7.1. Infectious Diseases
- 10.7.2. Diabetes
- 10.7.3. Oncology
- 10.7.4. Cardiology
- 10.7.5. Nephrology
- 10.7.6. Autoimmune Diseases
- 10.7.7. Drug Testing
- 10.7.8. Others
- 10.8. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
- 10.8.1. Hospitals
- 10.8.2. Laboratories
- 10.8.3. Home Care
- 10.8.4. Others
- 10.9. Market Attractiveness Analysis
- 11. Middle East & Africa In-vitro Diagnostics (IVD) Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product Type
- 11.2.3. By Technology
- 11.2.4. By Test
- 11.2.5. By Application
- 11.2.6. By End-use
- 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 11.4.1. Instruments
- 11.4.2. Reagents
- 11.4.3. Others
- 11.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 11.5.1. Immunoassay
- 11.5.2. Hematology
- 11.5.3. Clinical Chemistry
- 11.5.4. Molecular Diagnostics
- 11.5.5. Coagulation
- 11.5.6. Microbiology
- 11.5.7. Others
- 11.6. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
- 11.6.1. Point-of-care
- 11.6.2. Home Care
- 11.6.3. Others
- 11.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.7.1. Infectious Diseases
- 11.7.2. Diabetes
- 11.7.3. Oncology
- 11.7.4. Cardiology
- 11.7.5. Nephrology
- 11.7.6. Autoimmune Diseases
- 11.7.7. Drug Testing
- 11.7.8. Others
- 11.8. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
- 11.8.1. Hospitals
- 11.8.2. Laboratories
- 11.8.3. Home Care
- 11.8.4. Others
- 11.9. Market Attractiveness Analysis
- 12. Competition Landscape
- 12.1. Market Share Analysis, 2024
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Abbott Laboratories
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Product Types
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Siemens Healthineers AG
- 12.3.3. Bio-Rad Laboratories, Inc.
- 12.3.4. F. Hoffmann-La Roche Ltd.
- 12.3.5. Quidel Corporation
- 12.3.6. QIAGEN
- 12.3.7. Becton, Dickinson and Company
- 12.3.8. Danaher
- 12.3.9. BIOMÉRIEUX
- 12.3.10. Agilent Technologies, Inc.
- 12.3.11. Quest Diagnostics Incorporated
- 12.3.12. Others
- 13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
